Demographics, Clinical Characteristics, and Barriers to Care in Patients with Dyslipidaemia in the Arabian Gulf Region: The Gulf ACTION Registry [0.03%]
Khalid F Alhabib,Hanan B Albackr,Khalid Al Waili et al.
Khalid F Alhabib et al.
Introduction: This study evaluates dyslipidaemia management in the Arabian Gulf region. Methods: The multicentre, multinational longitu...
Nadji Hannachi,Antoine Mariotti,Laurence Camoin-Jau
Nadji Hannachi
Introduction: Statins exhibit pleiotropic effects with potential benefits in several infectious diseases, but their role in infective endocarditis (IE) remains unclear. We evaluated the impact of statin use on the frequen...
Antonis S Manolis,Antonis A Manolis,Theodora A Manolis et al.
Antonis S Manolis et al.
Chronic obstructive pulmonary disease (COPD) remains a significant global public health challenge, plagued by substantial morbidity and mortality worldwide; it is one of the main causes of death worldwide, especially during episodes of seve...
Cardiovascular Risks of Electronic Cigarettes: Mechanisms, Evidence, and Research Gaps [0.03%]
电子烟的心血管风险：机制、证据和研究缺口
Pandey Pratima,Anit Kumar Sinha,Basant Kumar
Pandey Pratima
Introduction: Electronic cigarettes (ECs), or electronic nicotine delivery systems (ENDS), are increasingly promoted as safer alternatives to conventional cigarettes, especially among younger populations. However, concern...
Hao Luo,Ningzhi Zhang,Yingying Liu et al.
Hao Luo et al.
Empagliflozin (EMPA), a sodium-glucose cotransporter 2 inhibitor (SGLT2i), represents a novel therapeutic agent for diabetes management. Over the past decade, studies have consistently demonstrated that EMPA not only effectively lowers bloo...
Hellenic Postprandial Lipemia Study (HPLS): A Prospective Cohort Trial on the Effect of Statins on Postprandial Hypertriglyceridemia [0.03%]
希腊餐后脂血症研究（HPLS）：他汀类药物对餐后高甘油三酯血症影响的前瞻性队列试验
Genovefa D Kolovou,Theodoros Katsikas,Petros Kalogeropoulos et al.
Genovefa D Kolovou et al.
Introduction/objective: Both fasting and postprandial hypertriglyceridemia are associated with atherosclerotic cardiovascular disease (ASCVD). The Hellenic Postprandial Lipemia Study (HPLS, NCT02163044) is the largest pro...
Metabolic Dysfunction-Associated Steatotic Liver Disease and Peripheral Arterial Disease: Associations and Treatment Considerations [0.03%]
代谢功能异常相关性脂肪肝病与外周动脉疾病的关系及治疗考虑因素
Stergios A Polyzos,Myrsini Orfanidou,Jannis Kountouras et al.
Stergios A Polyzos et al.
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) and peripheral arterial disease (PAD) are highly prevalent conditions that increase cardiovascular risk. This review aims to summarize current...
Determinants of Early Atherosclerotic Changes in Adults with Growth Hormone Deficiency Receiving Replacement Therapy: A Cross-sectional Analysis of Intima-media Thickness and Endothelial Function [0.03%]
生长激素缺乏成人接受替代治疗的早期动脉粥样硬化变化的决定因素：关于内膜-中膜厚度和内皮功能的横断面分析
Ana Klinc,Rok Herman,Tomaz Kocjan et al.
Ana Klinc et al.
Background: Patients with adult growth hormone deficiency (AGHD) show accelerated atherosclerosis. While growth hormone replacement therapy (GHRT) may help mitigate this process, the mechanisms driving atherosclerosis pro...
Does the Golden Hour for Cardiac and Vascular Immunology Run in Parallel? [0.03%]
心脏和血管免疫学的“黄金时间”是平行的吗？
Lorenzo Malatino,Agata Buonacera,Michele Colaci
Lorenzo Malatino
Management of Vascular Calcification in Hemodialysis: Efforts in Vain or Promising Strategies? [0.03%]
透析患者血管钙化的管理：徒劳的努力还是有前景的策略？
Stefanos Roumeliotis,Konstantinos Leivaditis,Eirini Leptokaridou et al.
Stefanos Roumeliotis et al.